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Aerobic cells adjust the expression of antioxidant enzymes to maintain reactive oxygen species within tolerable levels. In addition,
phosphatidylinositol 3 kinase (PI3K) and its downstream protein kinase effector Akt adapt cells to survive in the presence of oxidative
stress. Here we provide evidence for an association between these two defense systems via transcriptional regulation of Cu/Zn-superoxide
dismutase (Cu/Zn-SOD). PC12 pheochromocytoma cells expressing active Akt1 exhibit lower ROS levels in response to hydrogen perox-
ide, as determined with the superoxide-sensitive probe hydroethidine. Transfection of constitutive or 4-hydroxytamoxifen-inducible
versions of Akt1 results in higher messenger RNA and protein levels of Cu/Zn-SOD. Luciferase reporter constructs, carrying different
length fragments of the human sod1 gene promoter, have identified a region between –552 and –355 that is targeted by PI3K and Akt and
that contains a putative site of regulation by nuclear factor-B (NF-B). Nerve growth factor (NGF) and Akt augment the transactivating
activity and produce higher nuclear levels of p65-NF-B. Electrophoretic mobility shift assays indicate that the putative NF-B regulatory
sequence binds p65-NF-B more efficiently in nuclear extracts from these cells. A dominant-negative mutant of IB further demon-
strates that the PI3K/Akt axis targets the sod1 promoter at the level of the newly characterized NF-B site. These results illustrate a new
mechanism by which the PI3K/Akt pathway protects cells against oxidative stress, involving the upregulation of Cu/Zn-SOD gene expres-
sion, and the results identify NF-B as a key mediator in the regulation of this gene.
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Introduction
Reactive oxygen species (ROS) are generated during aerobic me-
tabolism or in response to external toxins and produce oxidative
damage to cellular macromolecules (Klein and Ackerman, 2003).
Adaptive responses adjust the abundance and activity of antiox-
idant systems to cellular needs (Fridovich, 1999). One such sys-
tem is constituted by the superoxide dismutase (SOD) enzymes,
which convert superoxide anion into molecular oxygen and hy-
drogen peroxide (H2O2) (Fridovich, 1997; Zelko et al., 2002).
Cu/Zn-SOD, the most abundant and ubiquitous isoform,
may have great physiological significance and therapeutic poten-
tial in neurodegenerative diseases because the CNS is particularly
sensitive to oxidant injury. For instance, an inverse correlation
has been reported between Cu/Zn-SOD activity and neuronal
death after acute brain injury (Takeuchi et al., 2000). Moreover,
the level of Cu/Zn-SOD mRNA was reduced significantly in the
substantia nigra of marmosets treated with the parkinsonian
toxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
and in patients with Parkinson’s disease (Kunikowska and Jen-
ner, 2003). In addition, Cu/Zn-SOD transgenic mice were pro-
tected against the neurotoxic effects of 6-hydroxydopamine (6-
OHDA) (Asanuma et al., 1998). Transcription of sod1, the gene
coding for Cu/Zn-SOD, is regulated tightly in response to diverse
stimuli, including stress, proinflammatory cytokines, and growth
factors (Kong et al., 1993; Yoo et al., 1999; Chang et al., 2002; Park
and Rho, 2002). However, despite the detailed characterization of
the regulatory promoter region, little is known about the intra-
cellular signaling cascades that govern sod1 expression.
The phosphatidylinositol 3 kinase (PI3K) and its best charac-
terized effector, the Ser/Thr protein kinase Akt/protein kinase B
(PKB), exert antioxidant effects in central and peripheral neu-
rons (Brunet et al., 2001; Franke et al., 2003). Recently, we have
reported the protective effect of active Akt1 against peptides of
-amyloid protein (Martin et al., 2001), against the Parkinson-
inducing toxins 1-methyl-4-phenylpyridinium (MPP) (Salinas
et al., 2001) and 6-OHDA (Salinas et al., 2003), and against apo-
ptotic concentrations of H2O2 (Martin et al., 2002). In these
cases, expression of a constitutively active version of Akt1 pre-
vented the increase in ROS that follows treatment of PC12 cells
with these neurotoxins. Despite these reports, a direct regulatory
role of this pathway on the canonical antioxidant defenses such as
Cu/Zn-SOD has not been demonstrated clearly.
The survival effect of PI3K and Akt generally is attributed to
Akt-mediated phosphorylation of proapoptotic proteins but also
to transcription-dependent mechanisms (Kuruvilla et al., 2000;
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Brunet et al., 2001). Several transcription factors have been iden-
tified as substrates of Akt that might mediate Akt actions on gene
expression of antioxidant enzymes. Akt directly phosphorylates
the Forkhead transcription factors of the FOXO class (Brunet et
al., 1999) and may participate in the activation of cAMP response
element binding protein (CREB) (Du and Montminy, 1998) and
nuclear factor-B (NF-B) (Kane et al., 1999).
In this study we report that the PI3K/Akt axis upregulates the
expression of Cu/Zn-SOD via the activation of NF-B. These
data contribute to reveal the mechanism whereby PI3K/Akt pro-
vide protection against oxidative injury and suggest a new thera-
peutic strategy to increase the antioxidant capacity of neurons via
the activation of this survival pathway.
Materials and Methods
Cell culture and reagents. Rat pheochromocytoma PC12 cells [gift of Dr.
H. Kleinman, National Institute of Dental and Craniofacial Research
(NIDCR), National Institutes of Health (NIH), Bethesda, MD] were
grown in DMEM supplemented with 7.5% heat-inactivated fetal bovine
serum, 7.5% heat-inactivated horse serum, and 80 g/ml gentamycin.
PC12 cells stably expressing myr-Akt1-ER* were grown in medium sup-
plemented with serum treated with charcoal-coated dextran (Sigma–
Aldrich, Madrid, Spain). Stable transfections with the expression vectors
pCEFL(X –)EGFP, pCEFL(X –)myr-EGFP-Akt1, and pcDNA3-myr-
Akt1-ER* were made with SuperFect transfection reagent (Qiagen, Va-
lencia, CA) according to the manufacturer’s instructions. Transfected
cells were selected in 0.5 mg/ml G418. Other reagents were nerve growth
factor (NGF) (Promega, Madison, WI), H2O2, glutathione, LY294002,
and 4-hydroxytamoxifen (4-HT; Sigma–Aldrich).
Plasmids. Constructs expressing the EGFP-Akt1 fusion proteins were
generated as previously described (Salinas et al., 2001). For generation of
pcDNA3-myr-Akt-ER*, the BamHI/EcoRI fragment of pBluescript
KSMER (Littlewood et al., 1995) was subcloned in the same sites of
pcDNA3.myr-Akt1 (Salinas et al., 2000). This fragment comprises a mu-
tant hormone-binding domain of the estrogen receptor (ER*) that does
not bind -estradiol but retains responsiveness to the synthetic steroid
4-HT. Then we put myr-Akt1 and ER* in the same reading frame and
removed the stop codon of myrAkt1 by using a PCR strategy (details
available on request). Expression vectors for anchored membrane forms
of myristoylated Akt1 and farnesylated PI3K included the following:
pcDNA3-myr-EGFP-Akt1 (Salinas et al., 2000), pSG5gag-Akt1, and
pSG5p110-PI3K-CAAX (gift of Dr. J. Downward, Imperial Cancer Re-
search Fund, London, UK). From pSG5p110-PI3K-CAAX the EcoRI
fragment containing the coding sequence for PI3K-CAAX was subcloned
into vector pTG6600 under the control of the CMV promoter; pCMV-
m1, expressing the muscarinic m1 receptor, was a gift of Dr. S. Gutkind
(NIDCR, NIH, Bethesda, MD); NF-B-HIV contains the NF-B site of
the HIV enhancer/promoter (Montaner et al., 1999). Other expression
vectors were double-point mutant IB(S32A/S36A) (Traenckner et al.,
1995) and pGal4-p65 and pGal4-LUC (Montaner et al., 1999; Madrid et
al., 2000). Deletion mutants from the 5 flanking region of sod1 were
generated by following the same strategy described in Minc et al. (1999).
Briefly, PCR fragments of different lengths were amplified from the 5-
flanking region of the human sod1 gene by using Taq Gold DNA poly-
merase (Promega). For amplification of fragments –1499, –952, –750,
and –552, human genomic DNA was used as template, and a common
reverse primer was used (5-CCGAAAGCTTGAGACTACGACGC-
AAACCCAG-3) with a HindIII site to facilitate subsequent cloning.
Forward oligonucleotides were designed according to the size of the fu-
ture fragment: –1499 bp, 5-CCGACTCGAGCCCTTGGCAAGTTTA-
CAATG-3; –952 bp, 5-CCGACTCGAGGTGGTCCCAGGTACTT-
GGGGA-3; –750 bp, 5-CCGACTCGAGTATTTCCCTTGAAAGG-
TAAG-3; –552 bp, 5-CCGACTCGAGACCGAATTCTGCCAACC-
AAA-3. A XhoI site was introduced in all forward primers to allow
directional cloning into the reporter vector pGL3basic (Promega). Am-
plifications were performed by using 20 ng, with a thermal profile of (1)
96°C, 3 min; (2) 96°C, 2 min; (3) 65°C, 2 min; (4) 72°C, 3 min; (5) 40 to
2; (6)72°C, 5 min. The amplified fragments were introduced in
pGL3basic between the XhoI and HindIII sites. PCR fragments –355,
–157, –71, and –29 were amplified by using plasmid pGL3basic-sod1-
1499 as template and the reverse primer 5-ATAGGATCTCTG-
GCATGCGAGAATCTCACG-3, in which an SphI is introduced to allow
subsequent cloning. Forward oligonucleotides included the following:
–355 bp, 5-CCGACTCGAGTGGCCAAACTCAGTCATAAC-3; –157
bp, 5-CCGACTCGAGACGCGCCCCTTGCCCCGCCC-3; –71 bp, 5-
CCGAACTCGAGATTGGTTTGGGGCCAGAGTG-3; and –29 bp, 5-
CCGACTCGAGTATAAAGTAGTCGCGGAGAC-3. The amplified
fragments were subcloned in pGL3basic between sites XhoI and SphI.
NF-B-sod1 and NF-B-mut were obtained with the following oligonu-
cleotides: 5-CTAGCAAAGGTAAGTCCCGGATCCAAAGGTAAGTC-
CCGGATCAAGGTAAGCCCGGC-3 and 5-CTAGCAAAGGTAAGT-
ATTGTCGACAAAGGTAAGTTACGGATCAAGGTAAGTATTGGC-3
(underlined sites, NF-B). These oligonucleotides were subcloned into
NheI and XhoI sites of the minimal sod1 promoter pGL3basic-sod1-29.
Luciferase assays. PC12 cells were seeded in 24-well plates (75,000 cells
per well), cultured for 16 hr, and transfected with a DNA mixture con-
sisting of 100 ng of the appropriate luciferase construct and 400 ng of the
effector plasmid or empty vector, using Lipofectamine reagent (Invitro-
gen, Carlsbad, CA) according to the manufacturer’s recommendations.
After 24 hr from transfection the cells were serum-starved for 16 hr,
lysed, and assayed for luciferase activity with the Luciferase Assay System
(Promega) according to the manufacturer’s instructions; relative light
units were measured in a BG1 Optocomp I, GEM Biomedical luminom-
eter (Sparks, NV).
Analysis of mRNA levels by reverse transcriptase-PCR. Total cellular
RNA was extracted with Trizol reagent (Invitrogen). Equal amounts (1
g) of RNA from each treatment were reverse-transcribed (75 min,
42°C), using 5 U of avian myeloblastosis virus reverse transcriptase (RT)
in the presence of 20 U of RNasin (Promega). cDNA amplification was
performed in 25 l of PCR buffer [containing (in mM): 10 Tris-HCl, 50
KCl, 5 MgCl2, plus 0.1% Triton X-100, pH 9.0] containing 2.5 mM
digoxigenin-dUTP, 0.6 U of Taq DNA polymerase (Promega), and 30
pmol of synthetic gene-specific primers for Cu 2/Zn 2-SOD (forward,
5-TTCGAGCAGAAGGCAAGCGGTGAA-3; reverse, 5-AATCCCAA-
TCACACCACAAGCCAA-3). To ensure that equal amounts cDNA
were added to the PCR, we amplified the -actin housekeeping gene by
using synthetic oligonucleotides (forward, 5-TGTTTGAGACCTTCAA-
CACC-3; reverse, 5-CGCTCATTGCCGATAGTGAT-3). After an ini-
tial denaturation step (4 min at 94°C) the amplification of each cDNA
was performed at the optimal number of cycles within linear range (data
not shown), 19 cycles, using a thermal profile of 1 min at 94°C (denatur-
ation), 1 min at 58°C (annealing), and 1 min at 72°C (elongation). The
amplified PCR products were resolved in 1.8% agarose gel electrophore-
sis and transferred to nylon membranes (Biodyne, Pall Corporation,
New York, NY). Chemiluminescence detection was performed with a
digoxigenin luminescence detection kit (Roche Molecular Biochemicals,
Basel, Switzerland).
Immunoblotting. The primary antibodies used were anti-Cu 2/Zn 2-
SOD (StressGen, Victoria, British Columbia, Canada), anti-p65, anti-
Sp1, anti-IB, and anti-Akt1C20 (Santa Cruz Biotechnology, Santa
Cruz, CA); anti-phospho-Thr 308Akt1 (New England Biolabs, Beverly,
MA); and anti-protein-disulfide-isomerase (gift from Dr. J. G. Castan˜o,
Chief Advisor of Scientific Investigations, Institute of Biomedical Inves-
tigations, Auto´noma University of Madrid). Cells were washed once with
cold PBS and lysed on ice with 200l of lysis buffer [containing (in mM):
137 NaCl, 20 Tris-HCl, pH 7.5, 1 phenylmethylsulfonyl fluoride, 20 NaF,
1 sodium pyrophosphate, and 1 Na3VO4 plus 1% Nonidet P-40, 10%
glycerol, 1g/ml leupeptin]. Precleared cell lysates were resolved in SDS-
PAGE and transferred to Immobilon membranes (Millipore, Billerica,
MA). These membranes were analyzed by using the primary antibodies
indicated above and peroxidase-conjugated secondary antibodies. Pro-
teins were detected by enhanced chemiluminescence (Pierce Biotechnol-
ogy, Rockford, IL). Densitometric analyses of representative immuno-
blots were performed with NIH Image software (Bethesda, MD).
Flow cytometry. Intracellular ROS were detected with hydroethidine
(HEt; Molecular Probes, Leiden, The Netherlands) (bandpass, 575/24
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nm filter), using a FACScan flow cytometer (BD Biosciences, Madrid,
Spain). Cells were detached from the plates, washed with PBS, incubated
with 2 M HEt for 1 hr at 37°C, and analyzed immediately. Baseline
incorporation of the probe was determined in cells incubated in 2 M
HEt for 1 hr at 4°C. For Annexin-V-phycoerythrin (Annexin-V-PE)
staining the cells were detached mechanically after treatments and
washed twice with Annexin-V binding buffer [containing (in mM): 10
HEPES-NaOH, pH 7.4, 150 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2]. Cells were
resuspended in 100l of a 1:20 dilution of Annexin-V-PE (Bender Med-
Systems Diagnostics, Vienna, Austria) in Annexin-V binding buffer con-
taining 2M 7-aminoactinomycin D (7-AAD) and were incubated for 15
min at room temperature. Fluorescence was measured with bandpass
620/22 and 575/24 nm filters. For immunostaining the cells were fixed
with 4% paraformaldehyde for 1 hr at 4°C, washed with PBS, permeabil-
ized with 0.2% Triton X-100 in PBS buffer for 5 min at 4°C, and incu-
bated for 1 hr with anti-Cu/Zn-SOD (1:100) diluted in PBS and for 1 hr
with Alexa 465-conjugated secondary antibody (1:500; Molecular
Probes) in PBS.
Confocal microscopy. Cells were seeded on glass-bottom 35 mm plates
(Willco, Amsterdam, The Netherlands) and incubated with 0.5 mM H2O2
for 3 hr and afterward with 2 M HEt for 1 hr at 37°C. Confocal micros-
copy was performed via a Leica SP2 system (Nussloch, Germany). For
HEt we used an excitation wavelength of 488 nm; fluorescence was de-
tected at wavelengths between 557 and 740 nm. For Hoechst 33258 we
used an excitation wavelength of 351 nm; fluorescence was detected at
wavelengths between 386 and 512 nm.
Preparation of nuclear and cytosolic extracts. Cytosolic and nuclear frac-
tions were prepared as previously described (Minc et al., 1999). Briefly,
5  10 6 cells were washed three times with cold PBS and harvested by
centrifugation at 1100 rpm for 10 min. The cell pellet was resuspended
carefully in three pellet volumes of cold buffer A [containing (in mM): 20
HEPES, pH 7.0, 0.15 EDTA, 0.015 EGTA, 10 KCl, 1 phenylmethylsulfo-
nyl fluoride, 20 NaF, 1 sodium pyrophosphate, and 1 Na3VO4 plus 1%
Nonidet P-40, 1 g/ml leupeptin]. Then the homogenate was centri-
fuged at 500 g for 5 min. The supernatant corresponding to the cyto-
solic fraction was resolved in SDS-PAGE and immunoblotted with anti-
p65, anti-IB, or anti-PDI antibodies. The nuclear pellet was
resuspended in five pellet volumes of cold buffer B [containing (in mM):
10 HEPES, pH 8.0, 0.1 EDTA, 1 phenylmethylsulfonyl fluoride, 20 NaF,
1 sodium pyrophosphate, and 1 Na3VO4 plus 25% glycerol, 0.1 M NaCl,
1 g/ml leupeptin]. After centrifugation in the same conditions indi-
cated above, the nuclei were resuspended in two pellet volumes of hyper-
tonic cold buffer C [containing (in mM): 10 HEPES, pH 8.0, 0.1 EDTA, 1
phenylmethylsulfonyl fluoride, 20 NaF, 1 sodium pyrophosphate, and 1
Na3VO4 plus 25% glycerol, 0.4 M NaCl, 1 g/ml leupeptin] and were
incubated for 30 min at 4°C in a rotating wheel. Nuclear debris was
removed by centrifugation at 900 g for 20 min at 4°C; the supernatant
was resolved in SDS-PAGE and immunoblotted with anti-p65 and anti-
Sp1 antibodies.
Electrophoretic mobility shift assays. The double-stranded wild-type
oligonucleotide used as an NF-B probe was 5-CTAGCAAAGGT-
AAGTCCCGGATCCAAAGGTAAGTCCCGGATCAAGGTAAGTCCC-
GGC-3 and for the mutant version was 5-CTAGCAAAGGTAAGTA-
T TGTCGACAAAGGTAAGTTACGGATCAAGGTAAGTATTGGC-3.
Then 250 ng/l of each oligonucleotide was annealed by incubation in
STE buffer [containing (in mM): 100 NaCl, 10 Tris-HCl, pH 8.0, and 1
EDTA] at 80°C for 2 min. The mixture was cooled down slowly to 4°C,
with a thermal profile of 1°C/min in a thermal incubator. Annealed
oligonucleotides were diluted to 25 ng/l in STE buffer. 5-End labeling
was performed with T4 polynucleotide kinase (Promega), using 25 ng of
double-stranded oligonucleotide and 25 Ci [ 32P]-ATP (3000 Ci/
mmol; Amersham Biosciences, Buckinghamshire, UK). The labeled
probes were purified in a G-25 spin column (Amersham Biosciences).
The binding reaction mixture contained 5 g of nuclear protein extract
diluted in a buffer containing, at final concentration, 40 mM HEPES, pH
8.0, 50 mM KCl, 0.05% Nonidet P-40, 1% dithiothreitol, and 10 g/ml
poly(dI-dC) in a total volume of 20 l. Antibody (2 g) or unlabeled
competitor probe (25 ng) was added, and the reaction was incubated for
1 hr at 25°C. Labeled DNA (0.25 ng) was added to the mixture and was
submitted to an additional 20 min of incubation at 25°C. Samples were
resolved at 4°C in a 5% nondenaturing polyacrylamide gel in 0.5 Tris-
borate/EDTA buffer. After electrophoresis the gel was dried and
autoradiographed.
Statistics. Student’s t test was used to assess differences between
groups. A p value 0.05 was considered significant. Unless indicated, all
experiments were performed at least three times with similar results. The
values in the graphs correspond to the mean of at least three samples.
Error bars indicate SD.
Results
To establish the conditions for analysis of ROS production under
oxidative stress, we maintained PC12 cells in low-serum medium
(1% fetal calf serum plus 1% horse serum) for 16 hr and then
submitted the cells to 0.5 mM H2O2 for 3 hr. During the last hour
of incubation the medium was supplemented with 2 M HEt, a
fluorescent probe most sensitive to anion superoxide, which with
oxidation converts into ethidium and emits orange fluorescence
(Bindokas et al., 1996; Chan et al., 1998). As shown in Figure 1A,
counterstaining of these cells with the nuclear dye Hoechst 33258
and analysis by confocal microscopy evidenced HEt accumu-
lation mostly in the nuclei of the cells submitted to oxidative
damage. Then we quantified the incorporation of HEt by flow
cytometry (Fig. 1B). Untreated cells exhibited a weak HEt incor-
poration. In contrast, H2O2 induced a significant increase in HEt
fluorescence, consistent with the intracellular generation of ROS
such as superoxide anion.
Next we analyzed the rate of HEt incorporation in PC12 cells
submitted to H2O2 alone or in combination with reduced gluta-
thione (GSH). As shown in Figure 1C, incubation with 0.5 mM
H2O2 for2 hr resulted in a three- to fourfold accumulation of
HEt fluorescence. Moreover, the addition of 10 mM GSH 30 min
before H2O2 treatment prevented the oxidation of HEt, as ex-
pected from its antioxidant properties.
To determine the role of the PI3K/Akt pathway in protection
against ROS toxicity, we used PC12 cells stably transfected with
expression vectors for enhanced green fluorescence protein
(EGFP), as a control, or an Akt fusion protein, myr-EGFP-Akt1,
containing EGFP at the N terminus of mouse Akt1 and a myris-
toylation signal that targets this chimera to the plasma membrane
and confers constitutive activation (Salinas et al., 2001). Figure
2A shows the endogenous 59 kDa Akt protein and the ectopically
expressed 85 kDa myr-EGFP-Akt1 fusion protein in EGFP- and
myr-EGFP-Akt1-transfected cells, respectively. In addition, as
shown in Figure 2B, when these cells were placed in low-serum
medium for 16 hr and analyzed with antibodies that specifically
recognize the phosphorylated, active form of Akt, we observed
that only myr-EGFP-Akt1 retains activity (for a more detailed
description of these constructs, see Salinas et al., 2001).
The presence of EGFP in the control cells or the EGFP moiety
in the myr-EGFP-Akt1 cells allowed for analysis of single living
cells by flow cytometry in combination with the orange fluores-
cence of HEt-stained cells. Cells maintained under low-serum
conditions for 16 hr were submitted to several H2O2 concentra-
tions for 3 hr and stained with HEt during the last hour. As shown
in Figure 2C, in the EGFP cells H2O2 induced a three- to fourfold
increase in the HEt fluorescence in a concentration range of 0.5–1
mM. Interestingly, the myr-EGFP-Akt1 cells exhibited a lower
basal level of HEt fluorescence and were much more refractory to
HEt incorporation in the presence of H2O2. These results indicate
that activation of the PI3K/Akt pathway exerts antioxidant effects
in PC12 cells.
In additional flow cytometry experiments, we confirmed that
the antioxidant effects elicited by the PI3K/Akt pathway corre-
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lated with protection against ROS-induced apoptosis. We ana-
lyzed exposure of phosphatidylserine on the outer plasma mem-
brane leaflet as an early hallmark of apoptosis. This alteration was
analyzed with Annexin-V-PE. To discriminate apoptosis from
necrosis, we stained the cells simultaneously with the red fluores-
cent vital dye 7-AAD, which enters cells lacking membrane integ-
rity and, therefore, allows for detection of necrotic cells (Hasper
et al., 2000). EGFP and myr-EGFP-Akt1 cells were maintained
under low-serum conditions for 16 hr and then were submitted
to 0.5 or 1.5 mM H2O2 for 6 hr and finally were stained for 15 min
with Annexin-V-PE and 7-AAD. As shown in Figure 2, D and E,
in the absence of H2O2 most cells were Annexin-V-PE- and
7-AAD-negative, indicating that they were viable. After 0.5 mM
H2O2 treatment 40% of the EGFP cells were Annexin-V-PE-
positive and 7-AAD-negative, indicating that this population was
undergoing apoptotic cell death. In contrast, in the myr-EGFP-
Akt1 cells this percentage was only 20%. On the other hand,
after 1.5 mM H2O2 treatment almost the entire populations of
EGFP and myr-EGFP-Akt1 cells were stained with both 7-AAD
and Annexin-V-PE. Therefore, these results indicate that the
PI3K/Akt pathway attenuates ROS-induced apoptosis, but not
necrosis.
Because the oxidant fluorescent probe used in this study, HEt,
is most sensitive for anion superoxide, we analyzed whether Akt
exerts its antioxidant effect via the activation of Cu/Zn-SOD. As
shown Figure 3, A and B, the basal messenger RNA and protein
levels of Cu/Zn-SOD were elevated significantly in myr-EGFP-
Akt1 cells, suggesting that Akt upregulates Cu/Zn-SOD expres-
sion. Moreover, as shown in Figure 3C, flow cytometry analysis of
EGFP and myr-EGFP-Akt1 cells immunostained with anti-Cu/
Figure 1. H2O2 increases intracellular ROS as determined by HEt staining. PC12 cells were
maintained in low-serum conditions for 16 hr and then untreated or incubated with 0.5 mM
H2O2 for 3 hr. During the last hour of the experiment, 2M HEt was added. A, Confocal micros-
copy pictures of representative fields from untreated and H2O2-treated cells stained with HEt
(HE) and Hoechst 33258. B, Flow cytometry analysis of H2O2-induced intracellular ROS produc-
tion in HEt-stained cells. A representative sample of 10,000 cells is shown for untreated or 0.5
mM H2O2-treated cells. C, Analysis by flow cytometry of the HEt incorporation rate in cells
submitted to 0.5 mM H2O2 in the absence and in the presence of 10 mM GSH.
Figure 2. PC12 cells expressing active Akt1 exhibit oxidant and apoptotic protection. PC12
cells were stably transfected with expression vectors for EGFP or myr-EGFP-Akt1. A, Immuno-
detection of endogenous Akt and ectopically expressed myr-EGFP-Akt1 with anti-Akt antibod-
ies. B, Immunodetection of active, phosphorylated Akt with anti-phospho-Akt antibodies. C,
Flow cytometry determination of ROS in PC12 cells submitted for 3 hr to the indicated H2O2
concentrations as described in Figure 1; *p 0.001. D, Determination by flow cytometry of
H2O2-induced apoptosis and necrosis in cells stained with Annexin-V-PE and 7-AAD. EGFP and
myr-EGFP-Akt1 cells were treated with 0.5 or 1.5 mM H2O2 for 6 hr and then stained for 15 min
with Annexin-V-PE (1:20 v/v) and 2M 7-AAD. A representative sample of 10,000 cells is shown
for each experimental condition. E, Comparison of the percentages of dead cells, determined
from Annexin-V-PE staining at the bottom right and top right quadrants in D, which represent
the total number of cells in apoptosis and necrosis. *p 0.001, comparing H2O2-treated EGFP
and myr-EGFP-Akt1 groups.
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Zn-SOD antibodies indicated that the levels of this enzyme were
increased two- to threefold in cells expressing active Akt1.
To confirm these observations further, we established a PC12
cell line transfected with an expression vector for a conditionally
active chimera of Akt, myr-Akt1-ER*. In this protein the myris-
toylated Akt was fused at its C-terminal end with a mutated ver-
sion of the hormone-binding domain from the estrogen receptor
(see Materials and Methods). This fusion protein is expressed in
an inactive form and becomes activated in the presence of 4-HT.
Figure 4A shows the expression of endogenous 59 kDa Akt and
the ectopically expressed 110 kDa fusion protein, and Figure 4B
shows that the addition of 1M 4-HT resulted in the activation of
this chimera as determined with activation-specific anti-
phospho-Akt1 antibodies. Interestingly, as shown in Figure 4, C
and D, when PC12 cells stably transfected with this construct
were used to assess the levels of Cu/Zn-SOD, we observed that the
addition of 4-HT for 16 hr induced the expression of both mRNA
and protein of this antioxidant enzyme in the myr-Akt1-ER* cells
and did not have a significant effect on control vector-transfected
PC12 cells.
In a previous study we reported that H2O2 induces a transient
activation of Akt but, in turn, results in inactivation and caspase
3-dependent and -independent degradation of Akt (Martin et al.,
2002). For that reason we analyzed the kinetics of Akt phosphor-
ylation/dephosphorylation and proteolytic degradation together
with the changes in Cu/Zn-SOD protein levels (Fig. 5). Control
EGFP-transfected cells exhibited a rise in phospho-Akt1 within
minutes after 0.5 mM H2O2 stimulation, but no phosphorylated/
active Akt was detected after 2 hr. In myr-EGFP-Akt1-transfected
cells a drop in phospho-Akt1 also was detected, but, in contrast to
control cells, a significant amount of phospho-EGFP-Akt1 re-
mained even after 4 hr. Moreover, control EGFP cells exhibited a
dramatic loss of total Akt protein after 2 hr of incubation with
H2O2, and Akt was no longer detectable after 4 hr. In myr-EGFP-
Akt1-transfected cells a drop in Akt1 levels also was detected, but
again a significant amount of Akt still was found after 4 hr. In
agreement with our previous study, these results suggest that
membrane-targeted active Akt is more resistant to H2O2-induced
dephosphorylation and degradation than the endogenous wild
type (Martin et al., 2002). In this experimental frame we analyzed
the changes in Cu/Zn-SOD protein levels. As shown in Figure 5,
in EGFP cells H2O2 induced a slight increase in Cu/Zn-SOD after
1 hr, as expected (Yoo et al., 1999). However, the amount of
Figure 3. PC12 cells expressing active Akt1 exhibit higher levels of Cu/Zn-SOD messenger
RNA and protein. A, Semi-quantitative RT-PCR of EGFP and myr-EGFP-Akt1 cells showing induc-
tion of Cu/Zn-SOD mRNA. Top, Cu/Zn-SOD mRNA; bottom, -actin mRNA showing a similar
amount of RNA per lane. B, Immunoblot showing the levels of Cu/Zn-SOD protein in the same
cells. Top, Blot with anti-Cu/Zn-SOD antibodies; bottom, blot with anti-PDI antibodies showing
a similar amount of protein per lane. C, Flow cytometry analysis of Cu/Zn-SOD protein levels in
EGFP and myr-EGFP-Akt1 cells after fixation, permeabilization, and staining with anti-Cu/Zn-
SOD antibodies.
Figure 4. Analysis of Cu/Zn-SOD levels in PC12 cells expressing a conditionally active version
of Akt1. PC12 cells, stably transfected with an expression vector for myr-Akt1-ER*, were sub-
mitted to 1M 4-HT for 16 hr under low-serum conditions. A, Immunodetection of endogenous
Akt and ectopically expressed myr-Akt1-ER* with anti-Akt antibodies. B, Immunodetection of
active, phosphorylated Akt with anti-phospho-Akt antibodies. C, Semi-quantitative RT-PCR of
vector- and myr-Akt1-ER*-transfected cells showing the levels of Cu/Zn-SOD mRNA in the pres-
ence and absence of 4-HT. Top, Cu/Zn-SOD mRNA; bottom, -actin mRNA showing a similar
amount of RNA per lane. D, Immunoblot showing the levels of Cu/Zn-SOD protein in the same
cells in the presence and absence of 4-HT. Top, Blot with anti-Cu/Zn-SOD antibodies; bottom,
blot with anti-PDI antibodies showing a similar amount of protein per lane.
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Cu/Zn-SOD dropped to undetectable levels after 4 hr. The drop
in Cu/Zn-SOD protein levels was prevented by preincubation
with the nonselective caspase inhibitor z-Val-Ala-Asp-
fluoromethylketone (zVAD-fmk) (data not shown). In contrast,
in myr-EGFP-Akt1 cells H2O2 did not increase Cu/Zn-SOD lev-
els over the basal ones, which are already high, suggesting that the
ectopic expression of active Akt saturated stimulation of Cu/Zn-
SOD expression. Moreover, Cu/Zn-SOD levels dropped after
long-term incubation with H2O2, but, in contrast to control cells,
a significant amount still could be detected after 4 hr. Therefore,
although these experiments do not demonstrate a causal relation-
ship between regulation of Akt and induction of Cu/Zn-SOD by
H2O2, they provide a mechanism that may be used, at least in
part, by ROS to upregulate Cu/Zn-SOD via activation of Akt (see
Discussion).
The regulatory effect of PI3K and Akt on expression of Cu/
Zn-SOD also was analyzed by using a luciferase reporter con-
struct carrying the luciferase gene under the control of 1499 bp
from the 5-flanking region of the human sod1 gene. As shown in
Figure 6, cotransfection of this construct with membrane-
targeted, active versions of PI3K (PI3K-CAAX) or Akt (myr-Akt1
and gag-Akt) resulted in a two- to threefold increase in luciferase
activity over the level of cells cotransfected with a control vector
carrying the muscarinic m1 receptor. Taken together, these re-
sults indicate that activation of the PI3K/Akt pathway increases
the cellular antioxidant capacity at least in part via the upregula-
tion of Cu/Zn-SOD expression.
There are several regulatory elements in the 5 promoter re-
gion of human sod1 that might be targets of the PI3K/Akt path-
way (Fig. 7A). To identify these targets, we generated several
deletions of the 1499 bp sod1 promoter and subcloned them into
the plasmid pGL3basic to govern luciferase expression. These
luciferase reporter constructs were transfected with control vec-
tor or with an expression vector for membrane-anchored, active
PI3K (PI3K-CAAX). As shown in Figure 7B, reporter constructs
–1499 to –552 exhibited both basal and PI3K-inducible activity.
In contrast, construct –355 exhibited basal activity, but no signif-
icant induction by PI3K. The smallest fragments –71 and –29
displayed low basal activity and little or no induction by PI3K.
These results indicate the existence of a highly sensitive site for
PI3K regulation between –355 and –552 bp of the human sod1 pro-
moter. As shown in Figure 7A, within this region we identified a
putative NF-B-responsive element (analysis by TFsearch software,
available at http://www.cbrc.jp/research/db/TFSEARCH.html).
Before the characterization of this site, we first verified the
functional activation of NF-B by the PI3K/Akt signaling path-
way in our system in the context of NGF stimulation. Regulation
of NF-B-dependent transcription involves at least two mecha-
nisms (Madrid et al., 2000): (1) modulation of the transactivating
domain located in the C-terminal 120 amino acids of p65 and (2)
release of transcription factor from the cytoplasmic inhibitor B
(IB) and subsequent translocation to the nucleus. To analyze
whether the PI3K/Akt pathway targets the transactivating do-
main (TD1) of p65-NF-B, we used a fusion protein consisting of
the p65-NF-B TD1 and the DNA-binding domain of Gal4.
PC12 cells were cotransfected with this expression vector (pGal4-
p65) and a reporter plasmid controlling luciferase expression via
four Gal4-responsive elements (pGal4-LUC). As shown in Figure
8A, in these cells NGF induced luciferase activity by more than
twofold. Interestingly, preincubation with the PI3K inhibitor
LY294002 significantly attenuated the NGF-induced luciferase
expression. In additional experiments we analyzed the regulation
of p65-NF-B transactivation domain 1 in the background of
EGFP and myr-EGFP-Akt1 cells. As shown in Figure 8A, when
cells were cotransfected with pGal4-p65 and pGal4-LUC, we ob-
served that myr-EGFP-Akt1 cells exhibited approximately four-
fold more luciferase activity than EGFP cells. These results indi-
cate that NGF regulates NF-B activity in a PI3K/Akt-dependent
manner by a mechanism directed, at least in part, to turn on the
transactivation domain of p65-NF-B. Because regulation of
Figure 5. Time course effect of H2O2 on Akt and Cu/Zn-SOD protein levels in control EGFP-
and myr-EGFP-Akt1-transfected cells. A, Cells incubated in low serum for 16 hr were submitted
to 0.5 mM H2O2 for the indicated times. Top, Immunoblots with anti-phospho-Akt antibodies.
Top middle, Immunoblots with anti-Akt antibodies. Bottom middle, Immunoblots with anti-
Cu/Zn-SOD antibodies. Bottom, Immunoblots with anti-PDI antibodies of the same lysates
showing similar amounts of protein per lane. B–D, Densitometric quantitation of phospho-Akt,
total Akt, and Cu/Zn-SOD levels relative to PDI levels after treatment with 0.5 mM H2O2 , as
shown in A.
Figure 6. Activation of the human sod1 promoter by the PI3K/Akt axis. PC12 cells were
transiently cotransfected with a luciferase reporter construct containing 1499 bp of the 5
regulatory sequence of human sod1 (pGL3basic-sod1-1499) and expression vectors for musca-
rinic receptor m1 as a negative control or for active PI3K-CAAX, gag-Akt, or myr-Akt1. After 24 hr
from transfection, the cells were maintained in low serum for 16 hr and then lysed and analyzed
for luciferase activity. *p 0.001, comparing m1 versus the other treatments.
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NF-B also involves nuclear translocation, we compared the nu-
clear levels of p65-NF-B after NGF stimulation in control EGFP
cells and in myr-EGFP-Akt1 cells. As shown in Figure 8B, the
basal levels of nuclear p65 were higher and those of cytosolic p65
were slightly lower in myr-EGFP-Akt1 cells as compared with
control EGFP cells. Accordingly, basal IB levels were slightly
lower in myr-EGFP-Akt1 cells. After 15 min of NGF stimulation
EGFP cells exhibited a transient increase of nuclear p65-NF-B,
whereas the levels of the housekeeping transcription factor Sp1
were stable. This transient translocation is consistent with obser-
vations by other authors (Maggirwar et al., 1998). In contrast,
NGF did not alter the distribution of p65-NF-B in myr-EGFP-
Akt1 cells, suggesting either that Akt promotes close to maximal
translocation or that Akt plays a substantial role as mediator of
NGF-induced regulation of this transcription factor. Interest-
ingly, although control EGFP cells exhibited higher basal IB
levels than myr-EGFP-Akt1 cells, NGF did not alter these levels
Figure 7. Identification of the sod1 promoter region that is regulated by PI3K. A, Schematic
showing candidate regulatory elements for PI3K in the human sod1 promoter and a detail of a
putative NF-B site at a position between –552 and –355 from the transcription start site. B,
PC12 cells were cotransfected with an expression vector for active PI3K-CAAX and luciferase
reporter constructs containing the indicated fragments of the human sod1 promoter. After 24 hr
from transfection, the cells were maintained in low serum for 16 hr and then lysed and analyzed
for luciferase activity. The figure shows folds of increase in luciferase activity over the promot-
erless vector pGL3basic. *p  0.001, comparing vector-transfected versus PI3K(CAAX)-
transfected groups.
Figure 8. Regulation of NF-B activity by NGF and Akt signaling. A, Effect on the transacti-
vating capacity of p65-NF-B. Left, PC12 cells were cotransfected with an expression vector for
a fusion protein consisting of the transactivation domain of p65-NF-B and the DNA-binding
domain of Gal4 (pGal4-p65) and a luciferase reporter under the control of Gal4 (pGal4-LUC).
After 24 hr from transfection, the cells were submitted to low-serum conditions for 16 hr and
then pretreated for 15 min with 10M LY294002 (LY) or treated with 25 ng/ml NGF for 6 hr, as
indicated. Right, EGFP and myr-EGFP-Akt1 cells were cotransfected with the same plasmids
(pGal4-p65 and pGal4-LUC), incubated in low serum for 16 hr, and analyzed for luciferase
activity. *Statistically significant differences, with p 0.001, comparing NGF-treated groups
and EGFP and myr-EGFP-Akt1 groups. B, Comparison of the nuclear and cytosolic p65-NF-B
and IB protein levels. EGFP and myr-EGFP-Akt1 cells were submitted to low-serum condi-
tions for 16 hr and then stimulated with 25 ng/ml NGF for the indicated times. Cell fractions
were resolved in SDS-PAGE and immunoblotted with anti-p65-NF-B and anti-IB antibod-
ies. The same blots were immunoblotted with anti-Sp1 and anti-PDI antibodies to demonstrate
similar protein load per lane.
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significantly under our experimental conditions, suggesting, in
agreement with previous reports (Bui et al., 2001), that NGF
induces at least in part the dissociation of p65-NF-B from the
NF-B/IB complex by a mechanism that does not necessarily
require IB degradation (see Discussion).
Taken together, those results indicated that the PI3K/Akt
pathway is necessary and sufficient for signaling to NF-B and
provided further support to analyze the regulation of sod1 via the
newly identified NF-B response element. Therefore, we used
electrophoretic mobility shift assays (EMSAs) to determine
whether the increase in nuclear p65-NF-B was sufficient to pro-
mote binding of this transcription factor to the putative NF-B
sequence of the human sod1 promoter. Nuclear extracts from
EGFP and myr-EGFP-Akt1 cells were incubated with a 32P-
labeled, double-stranded oligonucleotide comprising three tan-
dem copies of the putative sod1 NF-B sequence or a similar
probe mutated to abolish NF-B binding (see Materials and
Methods). As shown in Figure 9A, among the several retarded
complexes formed with the NF-B probe, one of them was barely
detectable in the mutated probe. In addition, the intensity of this
retarded band was increased significantly in the myr-EGFP-Akt1
nuclear extracts as compared with the EGFP ones. Moreover,
when an antibody against p65-NF-B was included in the bind-
ing reaction, the intensity of this retarded band decreased dra-
matically, indicating the presence of p65-NF-B in the complex.
These results support the existence of a p65-NF-B binding site
in this region of the sod1 promoter and its upregulation by the
PI3K/Akt pathway.
Finally, to analyze the functional regulation of the NF-B
binding site of sod1 by the PI3K/Akt pathway, we generated two
luciferase reporter constructs containing three wild-type (NF-
B-sod1) or three mutated (NF-B-mut) sequences of the 10 bp
corresponding to the putative NF-B regulatory element of hu-
man sod1 and linked them to the –29 luciferase sod1 reporter
construct. As a positive control of NF-B regulation, we also
analyzed the promoter activity of a well established NF-B regu-
latory sequence from human immunodeficiency virus (NF-B-
HIV). As shown in Figure 9B, PC12 cells cotransfected with active
PI3K-CAAX and either NF-B-sod1 or NF-B-HIV induced an
approximately threefold increase in luciferase activity over the
level of cells cotransfected with empty vector. In contrast, cells
cotransfected with NF-B-mut, p29-sod1, or pGL3basic yielded
similar luciferase activity in the presence of PI3K-CAAX or empty
vector. To demonstrate further a role of NF-B as a mediator of
PI3K regulation for this site, we used a dominant-negative mu-
tant of the inhibitor of NF-B, IB(S32A/S36A). This mutant
4
Figure 9. The NF-B site is sufficient to confer PI3K inducibility to the human sod1 pro-
moter. A, EMSA, using a double-stranded oligonucleotide with the putative NF-B sequence
(wild type) identified in the human sod1 promoter or a mutated control sequence (mutated)
and nuclear extracts from PC12 cells expressing EGFP or myr-EGFP-Akt1. The arrow points to the
position of a band that was not formed when the complexes were incubated in the presence of
anti-p65-NF-B antibody. B, Luciferase activity of PC12 cells cotransfected with PI3K-CAAX or
empty vector and reporter constructs comprising three wild-type tandem or three mutated
tandem sequences for the NF-B site of human sod1. In addition, the cells also were cotrans-
fected with a luciferase reporter construct for NF-B from human immunodeficiency virus
(NF-B-HIV), with p29-sod1, or with pGL3basic. *p  0.001, comparing vector-transfected
versus PI3K(CAAX)-transfected groups. C, Blockage of PI3K induction of the NF-B-responsive
element by cotransfection with dominant-negative IB(S32A/S36A) mutant. Cells were cotrans-
fected as in B plus the expression vector for IB(S32A/S36A). After 24 hr from transfection, the cells
were submitted to low-serum conditions for 16 hr and then analyzed for luciferase activity. *p
0.001, comparing vector-transfected versus IB(S32A/S36A)-transfected groups.
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contains two substitutions (S32A and S36A) that prevent its
phosphorylation and subsequent proteasomal degradation,
therefore exhibiting permanent sequestration of NF-B
(Traenckner et al., 1995). As shown in Figure 9C, IB(S32A/
S36A) blocked the PI3K-CAAX-mediated increase both in NF-
B-HIV and in NF-B-sod1 activities and did not have a signifi-
cant inhibitory effect on the activities of NF-B-mut, p29-sod1,
and pGL3basic. Taken together, these results indicate that the
PI3K/Akt pathway increases the cellular antioxidant defense at
least in part via the upregulation of Cu/Zn-SOD expression at the
level of the newly identified NF-B regulatory site.
Discussion
In this study we present evidence that the PI3K/Akt survival path-
way is involved in protection against oxidative damage by in-
creasing the expression of Cu/Zn-SOD. Cells expressing active
Akt1 kinase exhibited lower ROS levels in response to H2O2 and
higher mRNA and protein levels of Cu/Zn-SOD. In addition to
the regulation of Cu/Zn-SOD, we also observed mRNA and pro-
tein accumulation of other antioxidant enzymes, including Mn-
SOD (data not shown) and heme oxygenase-1 (Salinas et al.,
2003; Martin et al., 2004) in cells with an active PI3K/Akt path-
way. Of note, several groups including ours have reported the
activation of Akt in response to oxidative stress in a PI3K-
dependent manner (Konishi et al., 1997; Shaw et al., 1998; Martin
et al., 2002). According to these observations, it is tempting to
consider the PI3K/Akt axis as a sensor for intracellular ROS levels
that maintains ROS homeostasis via transcriptional activation of
antioxidant enzymes.
Activation of Akt by H2O2 correlated with an increase in Cu/
Zn-SOD levels. However, when cells were pretreated with the
PI3K inhibitor LY294002, we did not detect a decrease in Cu/Zn-
SOD expression (data not shown). Therefore, H2O2 induces sod1
via several overlapping mechanisms that may be Akt-dependent
and -independent. For instance, Yoo et al. (1999) have reported
the regulation of sod1 promoter by H2O2 at the level of hydrogen
peroxide-responsive (PPRE) and heat shock (HSE) elements.
These results illustrate (as shown in Fig. 7A) the complex tran-
scriptional regulation of this gene that probably involves multiple
positive and negative regulatory elements acting in concert.
Previous studies have reported the upregulation of Cu/Zn-
SOD in response to growth factors and neurotrophins (Kong et
al., 1993; Yoo et al., 1999; Chang et al., 2002; Park and Rho, 2002).
Our results also suggest that sod1 is subjected to NGF control via
PI3K/Akt/NF-B signaling. Here we report for the first time the
functional characterization of one NF-B site in human sod1 and,
most importantly, its regulation by the PI3K/Akt pathway. The
identified sequence starts at position – 486 and binds p65-NF-B.
Moreover, NGF activated the transactivation domain of p65-
NF-B in a PI3K/Akt-dependent manner and also produced a
transient translocation of this transcription factor to the nucleus,
therefore providing a mechanism to explain how Akt1 upregu-
lates Cu/Zn-SOD expression. The relevance of NF-B on the
PI3K/Akt1-mediated regulation of Cu/Zn-SOD expression was
demonstrated further by the fact that a dominant-negative IB
mutant prevented the sod1 promoter activation by PI3K-CAAX.
Interestingly, when we analyzed Cu/Zn-SOD protein levels after
NGF stimulation, we could detect barely a small increase after 4
hr of treatment (data not shown). Although we do not have a
conclusive explanation for this discrepancy, we suggest that
regulation of sod1 expression is submitted to an exquisite homeo-
static control via positive and negative regulatory elements, and,
therefore, NGF-induced stimulation requires either a very
strong/persistent activation of the PI3K/Akt pathway or cooper-
ation with other factors.
The regulation of NF-B by cytokine signaling, such as tumor
necrosis factor- (TNF-), has been established in detail (Hoff-
mann et al., 2002). The current model indicates that, under non-
stimulated conditions, p65-NF-B is sequestered in the cyto-
plasm via association with protein inhibitors of B (IB).
Cytokine stimulation promotes IB phosphorylation at serine
residue 32 by specific kinases (IKK) and subsequent targeting for
degradation by the ubiquitin–proteasome pathway. Therefore,
this model provides a mechanism for translocation of p65-
NF-B to the nucleus and heterodimerization with other NF-B
members for transcriptional regulation. However, the regulation
of NF-B activity by NGF and by Akt remains controversial. For
instance, Madrid et al. (2000) reported that Akt stimulates the
transactivation potential but barely increases the nuclear translo-
cation of p65-NF-B in HEK 293T cells. Regarding NGF, Bui et
al. (2001) reported the NGF-induced dissociation of the cytosolic
p65/IB complex via phosphorylation of IB at tyrosine resi-
due 42. Contrary to cytokine model, this mechanism results in
nuclear translocation of p65-NF-B without significant degrada-
tion of IB. On the other hand, Maggirwar et al. (1998) de-
scribed that NGF-induced NF-B contains heteromeric com-
plexes of p65 and p50 members and that NGF induces
degradation of IB, which is prevented by proteasome inhibi-
tors. The discrepancies among these studies may be related in
part to cell type specificity and methodological differences. For
instance, the Maggirwar study reported the partial degradation of
IB in cells isotopically labeled with 35S-methionine. In agree-
ment with this, we have observed a substantial decrease in IB
levels in cells submitted to the protein synthesis inhibitor cyclo-
heximide (data not shown). However, the studies that relied on
direct immunoblot detection of total IB might have missed
this observation because the expression of IB is upregulated by
NF-B as a negative feedback loop (Hoffmann et al., 2002), and,
therefore, the change in IB levels is very transient in NGF-
treated cells. The low rate of NGF-induced degradation of IB
in comparison to that of TNF- may argue against the relevance
of such degradation in this scenario. In any case, our results in
PC12 cells indicate that NGF induces the transactivating activity
of p65-NF-B in a PI3K-dependent manner and also induces its
transient nuclear translocation by a mechanism that requires lit-
tle or no contribution of IB degradation. In addition, the per-
sistent Akt activation also results in a sustained increase of nu-
clear p65-NF-B and a decrease of IB protein levels. Finally,
our results are in agreement with all of the above mentioned
studies in the observation that increased IB levels prevent ac-
tivation of p65-NF-B by Akt because the dominant-negative
mutant IB(S32A/S36A) substantially attenuated Akt-
mediated activation of the NF-KB regulatory site identified in the
human sod1.
In the 5-flanking region of human sod1 there are several pu-
tative binding sites for transcription factors that are regulated by
phosphorylation and might be targets of PI3K and Akt. These
include a CCAAT/enhancer binding protein (c/EBP), HSE, XRE,
ARE NF-B, and PPRE. Although some of these sites have been
studied in detail (Minc et al., 1999; Yoo et al., 1999; Chang et al.,
2002; Park and Rho, 2002), the regulation by NF-B has re-
mained unexplored. However, this site remains particularly at-
tractive to study the regulation of Cu/Zn-SOD because NF-B
family members are controlled by cell redox status and are in-
volved in cell survival (Mattson and Camandola, 2001; Karin and
Lin, 2002; Wang et al., 2002; Storz and Toker, 2003). Therefore,
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the upregulation of the antioxidant enzyme Cu/Zn-SOD by the
PI3K/Akt axis provides a connection between a transcription fac-
tor sensitive to redox regulation, such as NF-B, and a survival
pathway, represented by the PI3K and Akt.
Contrary to the observations reported in this study, Honda
and Honda (2002) have reported in Caenorhabditis elegans that
the absence of PI3K/Akt signaling results in activation of the
Forkhead transcription factor homolog DAF-16 and causes the
dauer phenotype, characterized by low metabolic rate and in-
creased resistance to oxidative stress. From consistent studies in
mammalian cells, Kops et al. (2002) have suggested that Akt and
Forkhead transcription factors of the FOXO family might exert
complementary functions in proliferating and quiescent cells. In
agreement with this hypothesis, we suggest that the PI3K/Akt axis
inversely regulates the subcellular distribution of NF-B and
FOXO transcription factors to adapt the level of antioxidant en-
zymes to specific metabolic situations. In the presence of neuro-
trophins, growth factors, or oxidative stress the activation of Akt
results in the direct phosphorylation of FOXO factors, causing
their displacement from the nucleus into the cytoplasm. Simul-
taneously, Akt induces translocation of NF-B to the nucleus and
activation of antioxidant genes. On the contrary, in quiescent
cells, where Akt is not active, most of NF-B is sequestered into
the cytoplasm while nonphosphorylated active FOXO transcrip-
tion factors localize to the nucleus and guard the proper expres-
sion of antioxidant genes. Together with Mn-SOD (Kops et al.,
2002), Cu/Zn-SOD might be included among the antioxidant
enzymes subjected to dual regulation by the pair NF-B/FOXO
because, in addition to the control exerted by PI3K/Akt/NF-B,
we have identified putative sites of regulation by Forkhead tran-
scription factors in the human sod1 gene (starting at positions
–1376, –1231, and – 822) that might be targets of FOXO members
under quiescent conditions.
Oxidative stress has been implicated in the neuronal cell death
of several neurodegenerative diseases such as Alzheimer’s and
Parkinson’s diseases. Strategies aimed to prevent the increase in
ROS during the course of these disorders may attenuate or stop
neuronal death and therefore may have significant clinical utility.
This study suggests that activation of the PI3K/Akt/NF-B path-
way might reinforce the antioxidant cell capacity and provide
protection against oxidant damage via the upregulation of anti-
oxidant genes such as sod1.
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